New developments in the use of prostatic stents

References

• Roehrborn CG. Male lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH). Med Clin North Am. 2011;95(1):87–100.
   PubMed Web of Science ®Google Scholar
• Mebust WK. Transurethral prostatectomy. Urol Clin North Am. 1990;17(3):575–585.
   PubMed Web of Science ®Google Scholar
• Kohler-Ockmore J, Feneley RC. Long-term catheterization of the bladder: prevalence and morbidity. Br J Urol. 1996;77(3):347–351.
   Google Scholar
• Kulkarni R. Metal ureteric stents: the current situation. BJU Int. 2003;92(3):188–189.
   Web of Science ®Google Scholar
• De Vocht TF, van Venrooij GE, Boon TA. Self-expanding stent insertion for urethral strictutes: a 10-year follow-up. BJU Int. 2003;91(7):627–630.
   Web of Science ®Google Scholar
• Masood S, Djaladat H, Kouriefs C, et al. The 12-year outcome analysis of an endourethral wallstent for treating benign prostatic hyperplasia. BJU Int. 2004;94(9):1271–1274.
   Web of Science ®Google Scholar
• Armitage JN, Cathcart PJ, Rashidian A, et al. Epithelializing stent for benign prostatic hyperplasia: a systematic review of the literature. J Urol. 2007;177(5):1619–1624.
   Web of Science ®Google Scholar
• Uchikoba T, Horiuchi K, Satoh M, et al. Urethral stent (Angiomed-Memotherm) implantation in high-risk patients with urinary retention. Hinyokika Kiyo. 2005;51(4):235–239.
   Google Scholar
• Fabian KM. The intra-prostatic “partial catheter” (urological spiral). Urologe A. 1980;9(4):236–238.
   Google Scholar
• Tomschi W, Luftenegger W. The urological spiral. A real alternative to the indwelling catheter? Experience in 23 patients. Wien Klin Wochenschr. 1990;102(21):650–653.
   Web of Science ®Google Scholar
• Braf Z, Chen J, Sofer M, Matzkin H. Intraprostatic metal stents (Prostakath and Urospiral): more than 6 years’ clinical experience with
   Google Scholar
• patients. J Endourol. 1996;10(6):555–558.
   Web of Science ®Google Scholar
• Yachia D, Aridogan IA. Comparison between first-generation (fixed-caliber) and second-generation (self-expanding, large caliber) temporary prostatic stents. Urol Int. 1996;57(3):165–169.
   Web of Science ®Google Scholar
• Staios D, Shergill I, Thwaini A, et al. The MemokathTM stent. Expert Rev Med Devices. 2007;4(2):99–101.
   PubMed Web of Science ®Google Scholar
• Armitage JN, Rashidian A, Cathcart PJ, et al. The thermo-expandable metal stent for managing benign prostatic hyperplasia: a systematic review. BJU Int. 2006;98(4):806–810.
   Web of Science ®Google Scholar
• Papatsoris AG, El-Husseiny T, Sawada Y, et al. Treating bladder-outflow obstruction with thermo-expandable prostate metal stents. Expert Rev Med Devices. 2009;6(4):357–363.
   Web of Science ®Google Scholar
• Minagawa T, Murata Y, Seki S. Placement of a shape-memory alloy intraurethral catheter (Memokath) using transrectal ultrasonography and fluoroscopy. Nippon Hinyokika Gakkai Zasshi. 2009;100(3):508–512.
   Google Scholar
• Song HY, Cho KS, Sung KB, et al. Self-expandable metal stents in highrisk patients with benign prostatic hyperplasia: long-term follow-up. Radiology. 1995;95(3):655–660.
   Google Scholar
• Van Dijk MM, Mochtar CA, Wijkstra H, et al. Hourglass-shaped nitinol prostatic stent in treatment of patients with lower urinary tract symptoms due to bladder outlet obstruction. Eur Urol. 2006;49(2):353–359.
   Web of Science ®Google Scholar
• Van Dijk MM, Mochtar CA, Wijkstra H, et al. The bell-shaped nitinol prostatic stent in the treatment of lower urinary tract symptoms: experience in 108 patients. Urology. 2005;66(4):845–849.
   Web of Science ®Google Scholar
• Markovic BB, Markovic Z, Yachia D, Hadzi DJ. A new generation of urethral stents: Allium in the therapy of symptomatic prostatic enlargement of various etiology. Acta Chir Iugosl. 2007;54(3):71–76.
   Google Scholar
• Vanderbrink BA, Rastinehad AR, Badlani GH. Prostatic stents for the treatment of benign prostatic hyperplasia. Curr Opin Urol. 2007;17(1):1–6.
   Web of Science ®Google Scholar
• Corica AP, Larson BT, Sagaz A, et al. A novel temporary prostatic stent for the relief of prostatic urethral obstruction. BJU Int. 2004;93(3):346–348.
   Web of Science ®Google Scholar
• Grimsley SJ, Khan MH, Lennox E, Paterson PH. Experience with the spanner prostatic stent in patients unfit for surgery: an observational study. J Endourol. 2007;21(9):1093–1096.
   Web of Science ®Google Scholar
• Kotsar A, Isotalo T, Juuti H, et al. Biodegradable braided poly(lactic-co-glycolic acid) urethral stent combined with dutasteride in the treatment of acute urinary retention due to benign prostatic enlargement: a pilot study. BJU Int. 2009;103(5):626–629.
   Web of Science ®Google Scholar
• Knutson T. Can prostate stents be used to predict the outcome of transurethral resection of the prostate in the difficult cases? Curr Opin Urol. 2004;14(1):35–39.
   Web of Science ®Google Scholar
• Erickson BA, McAninch JW, Eisenberg ML, et al. Management for prostate cancer treatment related posterior urethral and bladder neck stenosis with stents. J Urol. 2011;185(1):198–203.
   Web of Science ®Google Scholar
• Henderson A, Laing RW, Langley SE. A Spanner in the works: the use of a new temporary urethral stent to relieve bladder outflow obstruction after prostate brachytherapy. Brachytherapy. 2002;1(4):211–218.
   Google Scholar
• Carl J, Nielsen J, Holmberg M, et al. Clinical results from first use of prostate stent as fiducial for radiotherapy of prostate cancer. Acta Oncol. December 21, 2010. [Epub ahead of print].
   Web of Science ®Google Scholar
• Ogiste JS, Cooper K, Kaplan SA. Are stents still a useful therapy for benign prostatic hyperplasia? Curr Opin Urol. 2003;13(1):51–57.
   Web of Science ®Google Scholar
• Roupret M, Misrai V, de Fourmestraux A, et al. Clinical relevance of urethral stents (Urospiral 2™) placement in patients with prostatic obstacle and concomitant high-risk surgical status or neurological diseases: a feasibility and safety study. Neurourol Urodyn. September 21, 2010. [Epub ahead of print].
   Web of Science ®Google Scholar
• Yoon CJ, Song HY, Kim JH, et al. Temporary placement of a covered, retrievable, barbed stent for the treatment of hormone-induced benign prostatic hyperplasia: technical feasibility and histologic changes in canine prostates. J Vasc Interv Radiol. 2010;21(9):1429–1435.
   Web of Science ®Google Scholar
• Madersbacher S, Alivizatos G, Nordling J, Sanz CR, Emberton M, de la Rosette JJ. EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelins). Eur Urol. 2004;46(5):547–554.
   PubMed Web of Science ®Google Scholar